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Abstract.  We have analyzed the levels, subcellular 
distribution,  and target proteins of two calcium-modu- 
lated proteins,  S100 and calmodulin,  in differentiated 
and undifferentiated rat C6 glioma cells.  Undiffer- 
entiated and differentiated C6 cells express primarily 
the S100~5 polypeptide, and the S100~ levels are four- 
fold higher in differentiated compared to undiffer- 
entiated cells.  Double fluorescent labeling studies of 
undifferentiated cells demonstrated that S100~ staining 
localized to a  small region of the perinuclear cyto- 
plasm and colocalized with the microtubule organizing 
center and Golgi apparatus.  Analysis of differentiated 
C6 cells demonstrated that S100/3 distribution and 
Sl00~-binding protein profile changed significantly 
upon differentiation.  In addition,  the brain-specific iso- 
zyme of one S100-binding  protein,  fructose-l,6-bisphos- 
phate aldolase C, can be detected in differentiated but 
not undifferentiated C6 cells.  While changes in the 
subcellular distribution of calmodulin were not ob- 
served during differentiation,  calmodulin levels and 
calmodulin-binding protein profiles did change.  Al- 
together these data suggest that S100/3 and calmodulin 
regulate different processes in glial cells and that the 
regulation of the expression,  subcellular distribution, 
and target proteins of S100~ and calmodulin during 
differentiation is a complex process which involves 
multiple mechanisms. 
T 
HE interaction  of calcium with calcium  binding  pro- 
teins is one mechanism  by which calcium  is thought 
to regulate  cellular processes. One class  of calcium 
binding proteins,  the calcium-modulated  proteins,  appear to 
act as effector proteins and transduce  calcium signals into a 
cellular response by modulating  the  activity  of other pro- 
teins;  i.e., target proteins.  Two examples of calcium-modu- 
lated proteins are calmodulin  and  the S100 family of pro- 
teins.  Calmodulin is an ubiquitous,  eukaryotic  protein that 
activates several enzymes and appears to regulate many cel- 
lular  processes (for review see Klee and Vanaman, 1982). 
The S100 fraction is composed primarily of two similar pro- 
teins,  S100a  and  S100/3, which  share  '~50%  identity  in 
amino  acid  sequence (Isobe and  Okuyama,  1978; 1981). 
Available data suggest that  like calmodulin,  S100 proteins 
may also be multifunctional  effector proteins  (Baudier  and 
Cole, 1988; Hagiwara et al.,  1988; Zimmer and Van Eldik, 
1986). S100 proteins  and calmodulin  are particularly  abun- 
dant in brain tissue,  and the levels of both proteins  change 
during  nervous  system  development  (Zuckerman  et  al., 
1970; Stewart and Urban, 1972; Haglid et al., 1977). These 
data suggest that S100 and calmodulin play an important role 
in the function  and differentiation  of neural  cells  in vivo. 
Rat C6 glioma cells (Benda et al., 1968) possess antigens 
and enzymes characteristic  of both astrocytes and oligoden- 
drocytes, and retain patterns of hormonal responsiveness that 
are similar  to those found in normal glial cells in brain and 
in primary cultures (deVellis et al., 1977; McCarthy and de- 
Vellis,  1980). In addition,  morphological  differentiation  of 
C6 cells occurs under conditions  that  elevate intracellular 
cAMP (Willingham,  1976). During differentiation,  C6 cells 
develop long processes and their morphology resembles that 
of mature astrocytes.  Under these conditions  specific bio- 
chemical  changes  occur,  including  induction  of astrocytic 
markers such as glial  fibrillary  acidic  protein  (Raju et al., 
1980), 2':Y-cyclic nucleotide 3' phosphohydrolase  S100 pro- 
teins  (McMorris,  1977; Tabuchi  et al.,  1981), and the C 
isozyme of fructose-l,6-bisphosphate  aldolase (Kumanishi et 
al.,  1975). It is interesting  to note that,  in addition to being 
an astrocytic  marker (Sato et al.,  1972; Kumanishi  et al., 
1985), the C isozyme of aldolase has been identified as an 
intracellular  target protein of S100 (Zimmer and Van Eldik, 
1986). Since C6 cells express both S100 (Labourdette  and 
Marks,  1975; Zimmer and Van Eldik,  1988) and calmodulin 
(Brostrom and Wolff, 1974; Zimmer and Van Eldik, 1988), 
this cell line is an excellent system for studying the mecha- 
nisms by which multiple  calcium-modulated  proteins  func- 
tion during  astrocyte differentiation. 
Previous studies  in our laboratory  (Zimmer and Van EI- 
dik, 1988) focused on the regulation of S100 and calmodulin 
during  growth of C6 ceils in vitro.  We found that S100~ is 
the predominant  S100 protein in rat C6 cells and that it may 
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Golgi  apparatus  and/or  microtubule  organizing  center 
(MTOC). ~ Our  studies  also  suggested  that  changes  in 
S100~  and  S100~-binding  proteins  may  be  involved  in 
regulating S100-mediated  processes in C6 cells and that the 
levels of calmodulin and S100~ may be differentially regu- 
lated in these cells. Other laboratories have examined S100 
during differentiation of C6 glioma cells. In these studies, 
low  serum  or  serum-free  media  and/or  the  addition  of 
dibutyryl cAMP or agents which increase the intracellular 
level of cAMP have been used to induce differentiation of 
these cells. However, there are discrepancies in the literature 
regarding the extent of morphological differentiation of C6 
cells  under  various  culture conditions  (Fan  and  Uzman, 
1977;  Steinbach and Schubert,  1975). Some investigators 
have reported  that the levels  of the S100 proteins do not 
change during differentiation (Donta,  1973),  while others 
have  reported  that  S100  protein  levels  increase  during 
differentiation (Labourdette and Mandel, 1980; Higashida et 
al., 1985). These previous studies have not used S100o~- and 
S100/3-specific antibodies to determine if  the changes in S100 
levels  represent changes in the level of one or both of the 
S100 proteins. In addition, other mechanisms of regulation 
such as alterations in the subcellular distribution of the S100 
proteins and/or alterations in the complement of S100 target 
proteins in C6 cells have not been examined. To date, none 
of the studies on differentiation of rat C6 cells has analyzed 
the regulation of calmodulin during this process. 
To better understand the  function of multiple calcium- 
modulated proteins  in  glial cells,  we have compared  the 
level, subcellular distribution and target proteins of S100 and 
calmodulin in undifferentiated and differentiated C6 glioma 
cells. In our studies, we have also examined partially differ- 
entiated cells in an attempt to clarify the conflicting reports 
in the literature regarding the extent of morphological dif- 
ferentiation and S100 levels  in these cells. In addition, the 
relationship of S100~ with specific intracellular structures, 
in particular the Golgi apparatus and MTOC, has been exam- 
ined. Altogether our data suggest that regulation of the ex- 
pression,  subcellular  distribution,  and  target  proteins  of 
S100/3 and calmodulin during differentiation is a complex 
process which involves multiple mechanisms. 
Materials and Methods 
Cell Culture and Drug Treatment of Cells 
The rat C6 glioma cell line was obtained from the American Type Culture 
Collection (Rockville, MD) and grown in F10 media (Gibco Laboratories, 
Grand Island,  NY)  supplemented with  15%  (vol/vol) horse serum (Hy- 
Clone Laboratories, Sterile Systems, In.c., Logan, UT), 2.5% (vol/vol) FCS 
(HyClone Laboratories, Sterile Systems Inc.), 2 ttg/ml fungizone (E. R. 
Squibb &  Sons, Princeton, NJ), 50 U/ml penicillin, and 50/zg/ml strep- 
tomycin (Gibco Laboratories). For adaptation to growth in serum-free me- 
dia, C6 cells were grown in serum-containing media for 2 d after trypsiniza- 
tion,  the  culture  media  was  then  changed  to  PC-1  serum-free media 
(Ventrex Laboratories, Inc., Portland, ME) containing 5% (vol/vol) horse 
serum and antibiotics for 2 d, then PC-1  media containing 1%  (vol/vol) 
horse serum and antibiotics for 2 d, and finally PC-1 media containing only 
antibiotics. Stock cultures were maintained in T-flasks of 25 cm  2 surface 
1.  Abbreviations  used  in  this paper:  dcAMP,  N6-2'-O-dibutyryl cAMP; 
MTOC, microtubule organizing center; WGA, wheat germ agglutinin. 
area (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA) and grown 
at 37°C in a humidified atmosphere of 95%  air and 5% CO2.  Stock cul- 
tures were fed every 2 d and subcultured every 7 d by trypsinization. For 
differentiation and drug treatment experiments, cells were prepared as de- 
scribed below. In all studies cells were allowed to grow for at least 48 h and 
fed at least once before treatment. 
To depolymerize microtubules, cells were treated with 1 #g/ml N-deacyl- 
N-methyl-colchicine (demecolcine) (Sigma Chemical Co., St. Louis, MO) 
for 1-4 h at 37°C.  Demecolcine was stored at  -20°C as a  1 mg/ml stock 
solution in water. 
Differentiation of C6 Cells 
To induce morphological differentiation, cells were fed with fresh media 
containing N6-2'-O-dibutyryl cAMP (dcAMP) (Sigma Chemical Co.) at a 
final concentration of 1 mM. The ceils were incubated in dcAMP for 48 h 
before cell fractionation or immunofluorescence microscopy studies. At the 
end of dcAMP treatment the ceils were •80%  confuent. Control cells 
grown in media only (either serum-containing or serum-free) were also har- 
vested at similar cell densities. 
Purification of  Proteins 
Sl00ct,  S100/3, and calmodulin were purified from bovine brain as previ- 
ously described (Hertzberg and Van Eldik,  1987;  Lukas and Watterson, 
1988).  Rat brain aldolase was purified by using the procedure of Penhoet 
et al. (1969).  Rabbit skeletal muscle aldolase was obtained from Beehringer 
Mannheim Biochemicals (Indianapolis, IN). Aldolase C was purified from 
rat brain as previously described (Zimmer and Van Eldik,  1986). 
Antibody Preparation and Characterization 
Affinity-purified sheep antitubulin antibody was obtained from Southern 
Biotechnology Associates (Birmingham, AL). Rabbit antisera against bo- 
vine calmodulin (Van Eldik and Watterson, 1981), a synthetic peptide of ver- 
tebrate calmodulin (Van Eldik et al.,  1983),  and bovine brain SI00a and 
S100/3 (Zimmer and Van  Eldik,  1987)  were prepared as previously de- 
scribed. Immunoglobulin fractions were prepared by ammonium sulfate 
fractionation (0-50%) and DEAE-cellulose chromatography (Fahey and 
Terry,  1978). 
Radioimmunoassay 
Competition radioimmunoassays for calmodulin (Van Eldik and Watterson, 
1981) and S100~ and S100/3 (Zimmer and Van Eldik,  1987) were done as 
previously described. 
Fluorescence Microscopy 
Trypsinized cells were plated in 60-mm plastic petri dishes (Falcon Lab- 
ware, Becton, Dickinson & Co.) containing 11  ×  22-ram glass coverslips. 
At the appropriate cell density, the cells were treated with dcAMP or colchi- 
cine as described above. After rinsing in 0.137 M NaCI, 0.003 M KCI, 0.004 
M Na2HPOa,  0.015 M KH2PO4 buffer,  pH 7.5 (PBS), the coverslips were 
fixed in 2.5 % (vol/vol) paraformaldehyde (Polysciences, Inc., Warrington, 
PA) in PBS for 20 rain at room temperature, incubated in cold acetone at 
-20°C for 5 rain, and rinsed briefly in PBS. In addition to acetone, digito- 
nin (Sigma Chemical Co.) was also used as a permeabilizing agent. For 
these experiments, the coverslips were rinsed briefly in PBS and incuba~l 
in various concentrations of digitonin in PBS for 2 min at room temperature. 
The digitonin-permeabilized coverslips were then rinsed in PBS, fixed in 
paraformaldehyde as described above, and rinsed briefly in PBS. After per- 
meabilization, the coverslips were incubated in 50 p.l of rabbit anti-S100fl 
IgG diluted  1:2 or undiluted affinity-purified sheep antitubulin antibody 
(Southern Biotechnology Associates) in PBS for 60 rain at 37°C. After rins- 
ing briefly in PBS followed by two 15-min washes in PBS, the coverslips 
were  incubated in  50  /zl  of FITC-conjugated goat anti-rabbit or  rabbit 
anti-goat secondary antibody (ICN ImmunoBiologicals, Lisle, IL) at a 1:32 
dilution in PBS.  After two  15-rain  washes in PBS, the coverslips were 
mounted in glycerol-PBS (9:1),  pH 8.0, on glass slides. In some experi- 
ments, the coverslips were incubated in TRITC-conjugated wheat germ ag- 
glutinin (WGA) (E. Y. Laboratories, Inc., San Mateo, CA) diluted 1:20 in 
PBS for 20 min at room temperature, rinsed with PBS, and then mounted. 
Cells  were  examined  with  a  Leitz  Diavert  microscope  equipped  for 
epifluorescence with  appropriate  rhodamine and  fluorescein filters and 
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1600) with a 50x  oil (NA  1.0) planapochrornat objective. 
Preparation of Cell Pellet Fractions 
Extracts of cell pellets were prepared as previously described (Zimmer and 
Van Eldik, 1987). Briefly, after homogenization the particulate fraction was 
removed by centrifugation at 15,000 g for 30 min. The homogenate superna- 
rant was fractionated by ammonium sulfate precipitation into four fractions: 
a 0-45% pellet, a 45-60% pellet, a 60-80%  pH 4 pellet, and a 60-80% 
pH 4 supernatant. All samples were dialyzed against 1 mM ammonium bi- 
carbonate, lyophilized, resuspended in water, and stored at -800C. Protein 
concentrations were determined by the method of Lowry et al. (1951) using 
BSA as a standard. 
Gel Overlay Analysis 
Electrophoresis on 12.5 % (wt/vol) acrylamide-(SDS) minigels and overlay 
analysis with iodinated proteins were done as previously described (Zimmer 
and Van Eldik,  1987). 
Gel Electrophoresis and Detection of  Aldolase Hybrids 
Aldolase hybrids were separated by gel electrophoresis and detected by an 
activity slain as previously described (Zimmer and Van Eldik,  1986). 
Results 
Relationship of SlOOf3 and Cellular Organdies 
Our previous immunolocalization studies (Zimmer and Van 
Eldik, 1988) demonstrated that S100/~ is localized to a small 
region of the perinuclear cytoplasm in C6 cells; we postu- 
lated that  this  region of the cytoplasm might contain the 
Golgi apparatus and/or MTOC. To test directly the hypothe- 
sis that S100/~ is associated with the Golgi apparatus in C6 
cells, a double-labeling experiment was performed in which 
TRITC-WGA was used to localize the Golgi apparatus (Virta- 
nen et al.,  1980) and an anti-Sl00/3 antibody and a FITC- 
conjugated secondary antibody were used to localize S100/3. 
The results of these experiments are shown in Fig.  1. When 
0.2%  digitonin was used to permeabilize the cells,  S100/~ 
(Fig.  1 a) and TRITC-WGA (Fig.  1 b) staining colocalized 
to the same region of the perinuclear cytoplasm. However, 
the TRITC-WGA staining  pattern was vesicular while the 
S100/~ staining pattern was diffuse. The Golgi apparatus also 
colocalized with the MTOC as revealed by double-labeling 
experiments in  which antitubulin antibodies  were used to 
localize the MTOC (Fig.  1 e) and TRITC-WGA was used to 
localize the Golgi apparatus (Fig.  I f). Similar results were 
obtained when cold acetone rather than digitonin was used 
to permeabilize the ceils (Fig. 2, a  and c). These double- 
labeling  experiments  demonstrate  that  the  perinuclear 
cytoplasm of C6 cells, which contains S100~ immunoreac- 
tivity, also contains the Golgi apparatus and MTOC. 
Previous studies have suggested that S100~ might be ac- 
tively secreted from C6 cells (Van Eldik and Zimmer, 1987). 
Since many secreted proteins are located on the inside of the 
Golgi membranes,  these  studies  raise the possibility that 
SI00/~ is located on the inside of the Golgi membranes. To 
investigate further the relationship of S100/~ and the Golgi 
apparatus, concentrations of digitonin, which would selec- 
tively permeabilize the plasma membrane and not the Golgi 
membranes, were used to permeabilize the cell before label- 
ing (Fiskum et al.,  1980). In these experiments antibodies 
to tubulin (which is located on the outside of the Golgi mem- 
branes) and TRITC-WGA (which binds to glycosylated pro- 
teins found inside the Golgi membranes) were used to moni- 
tor  the  permeability of the plasma  membrane  and  Golgi 
membranes, respectively. When the digitonin concentration 
was lowered to 0.01%,  a low level of TRITC-WGA labeling 
was observed throughout the cytoplasm in a punctate pattern 
(Fig. 1, d and h) but no intense perinuclear labeling was seen. 
These results indicate that in cells permeabilized with 0.01% 
digitonin the Golgi membranes are not permeable to WGA 
and suggest that they would not be permeable to other macro- 
molecules such as antibodies. Incubation of the cells in an- 
titubulin antibody (Fig.  1 g) produced a  labeling pattern 
which was identical to that seen in cells permeabilized with 
0.2%  digitonin (Fig.  1 e) or acetone, confirming that the 
plasma membrane of ceils treated with 0.01% digitonin was 
permeable to antibody molecules. In cells treated with 0.01% 
digitonin and incubated in S100/~ antibodies (Fig.  1 c), the 
staining observed was very similar to that seen in cells that 
were permeabilized with 0.2% digitonin (Fig.  1 a); i.e., in- 
tense staining in a small region of the perinuclear cytoplasm 
with a  low level diffuse cytoplasmic staining.  It should be 
noted that these experiments are not quantitative and a small 
reduction in S100fl  staining intensity in cells in which the 
Golgi membranes are not permeable would not be detected. 
Thus, our studies cannot rule out the possibility that a small 
portion of the intracellular S100B immunoreactivity is lo- 
cated inside the Golgi membranes. Nonetheless, the fact that 
S100tff immunoreactivity is present in C6 cells in which the 
Golgi membranes are not permeable to antibody molecules 
demonstrates that most of the S100/~ immunoreactivity is lo- 
cated outside of the Golgi membranes in the cytoplasm of the 
cell. 
The colocalization of S100/~ with the MTOC and previous 
reports which have shown that S100/~ colocalizes with the 
mitotic spindle (Zimmer and Van Eldik, 1988) and affects in 
vitro  microtubule assembly  (Donato,  1985;  Baudier  and 
Cole, 1988) suggest that one function of S100B may be the 
regulation of cell motility and/or cell architecture via inter- 
action with microtubules and/or microtubule-associated pro- 
teins. To examine more closely the association of SI00/~ with 
the  MTOC,  we  examined  the  subcellular  distribution  of 
S100~ in C6 cells in which the integrity of the microtubule 
network had been disrupted. In C6 cells treated with 1 or 5 
/zg/ml colchicine, no antitubulin staining was observed (Fig. 
2f) suggesting that colchicine treatment disrupted the cyto- 
plasmic microtubules.  When colchicine-treated cells were 
incubated in TRITC-WGA (Fig. 2 d), a punctate staining pat- 
tern was observed throughout the cytoplasm, rather than a 
small region of the perinuclear cytoplasm, suggesting that 
the Golgi apparatus had been disrupted. The dependency of 
the perinuclear arrangement of the Golgi apparatus on an in- 
tact microtubule complex has been observed in many cell 
types (Rogalski and Singer, 1984). When colchicine-treated 
C6 cells were incubated in S100~ antibodies a very low level 
of diffuse staining throughout the cytoplasm was  observed 
(Fig.  2  b)  and  this  staining  did  not  colocalize with  the 
TRITC-WGA-Iabeled vesicles.  Thus,  significant  levels  of 
S100~ immunoreactivity do not redistribute with the Golgi 
vesicles in colchicine-treated C6 cells. These data are consis- 
tent with  the  selective permeabilization studies  described 
above and suggest that significant levels of S100B are not 
found in the inside of the Golgi apparatus or intimately as- 
sociated with the outside surface of the Golgi membranes. 
Zimmer and Van Eldik SIO0 and Calmodulin  in Glial  Cell Differentiation  143 l~gure 1. Subcellular localization of S100/3 and tubulin in digitonin-permeabilized rat C6 cells. Fluorescent micrographs of C6 ceils which 
were permeabilized with 0.2 (a, b, e, and f) or 0.01% digitonin (c, d, g, and h) are shown. The permeabilized cells were labeled with 
an anti-S100B IgG  fraction, followed by a FITC-conjugated goat anti-rabbit secondary antibody and TRITC-WGA (a-d) or with an antitubu- 
lin antibody followed by an FITC-conjugated rabbit anti-sheep secondary antibody and TRITC-WGA (e-h). Cells in a, c, e, and g were 
viewed by optics selective for fluorescein to visualize the distribution of S100/~ (a and c) or microtubules (e and g). The same fields were 
viewed with optics selective for rhodamine to visualize the distribution  of WGA binding sites (b, d, f, and h).  Bar, 100/~m. 
These results along with the observation that S100B distribu- 
tion in the perinuclear cytoplasm is dependent on an intact 
cytoskeleton  suggest  that  S100B  is  associated  with  the 
MTOC. 
Morphological Differentiation of C6 Cells 
In previous studies (Fan and Uzman,  1977;  Steinbach and 
Schubert,  1975) the degree of morphological differentiation 
of C6 cells has varied from laboratory to laboratory and may 
be a result of the different culture conditions (i.e., presence 
or absence of serum) used in the different laboratories. To 
determine whether serum affects morphological differentia- 
tion of C6 cells,  we examined the effect of dcAMP on the 
morphology of C6  cells  grown  in  serum-containing  and 
serum-free media. Since previous studies in our laboratory 
(Zimmer and Van Eldik,  1988)  have demonstrated that the 
levels of S100  and calmodulin vary with cell density, all of 
the cells used in the present study were harvested at •80% 
confluency. In serum-containing media, C6 cells had a bipo- 
lar appearance (Fig. 3 a). C6 cells grown in serum-contain- 
ing media supplemented with dcAMP (Fig. 3 b) and C6 cells 
adapted to growth in serum-free media (Fig. 3 c) had similar 
morphologies,  appearing  larger  and  more  elongated  than 
cells grown  in  serum-containing media.  We refer to these 
cells as being partially differentiated although there is no di- 
rect evidence that these cells represent a true intermediate in 
the differentiation process. 
When C6 cells that had been adapted to growth in serum- 
free media were treated with dcAMP (Fig. 3 d), the cell bod- 
ies  became rounded  and  elaborated  numerous,  long  pro- 
The Journal of Cell Biology, Volume  108, 1989  144 Figure 2.  Subcellular  localization  of SI00~ in colchicine-treated  rat C6 ceils.  Fluorescent micrographs of C6 cells  that were incubated 
for 4 h in media containing  1 #g/ml colchicine (b, d, and f) or in media containing an equivalent volume of water (a, c, and e). Cells were 
permeabilized with cold acetone and labeled with an S100/3 IgG fraction, followed by an FITC-conjugated secondary antibody and TRITC- 
WGA (a-d), or with an antitubulin  antibody (e and f) followed by an FITC-conjugated secondary antibody.  Cells  in a, b, e, andfwere 
viewed by optics selective  for fluorescein  to visualize  SI00/~ (a and b) or tubulin  (e and f) distribution.  The fields shown in a and b were 
also viewed  with optics selective  for rhodamine to visualize  the distribution  of WGA binding  sites  (c and d).  Bar,  10 #m. 
cesses.  The  morphology of these  cells  resembled  that  of 
mature astrocytes. It should be noted that this cell population 
was heterogeneous with some cells being bipolar and others 
multipolar. In control experiments in which sodium butyrate 
was added to the media instead of dcAMP, no morphological 
changes were observed, suggesting that increased intracellu- 
lar cAMP levels, and not butyrate, were responsible for the 
morphological changes observed  (data  not  shown).  Other 
cAMP analogs, including 8-bromo-cAMP, 8-(4-chlorophen- 
ylthio)-cAMp,  N6-benzoyl-cAMP,  and  N~-monobutyryl  - 
cAMP,  also  induced  morphological  changes  identical  to 
those seen with dcAMp, suggesting that increased intracellu- 
lar  cAMP  levels  were  responsible  for  the  morphological 
changes  observed.  Altogether  our  data  demonstrate  that 
dcAMP causes  a  morphological differentiation  of C6 cells 
and that the effects of dcAMP on C6 cell morphology vary 
depending on the serum composition of the media. 
Zimmer and Van Eldik SIO0 and Calmodulln in Glial Cell Differentiation  145 Figure 3. Morphological features of rat C6 cells grown under various culture conditions. Phase contrast micrographs of C6 cells grown 
in (a) serum-containing media, (b) serum-conlaining media supplemented with I mM dcAMP, (c) serum-free media, and (at) serum-free 
media supplemented with 1 mM dcAMP. Treatment of C6 cells grown in serum-free media with 1 mM dcAMP produced a heterogeneous 
population of cells which contained both bipolar (arrowheads) and multipolar (arrows) cells. Bar, 1 tam. 
lntraceUular Levels of SlOO~t, S100[3, and Calmodulin 
The levels of  S100ct, S100/3, and calmodulin in differentiated, 
partially differentiated, and undifferentiated C6 cells were 
determined by radioimmunoassay  using  rabbit polyclonal 
antisera. The S100a and S100/~ antisera used in these studies 
exhibited no reactivity with purified eaimodulin and exhib- 
ited <5 % cross-reactivity with S100~ or S100ot, respectively 
(Zimmer and Van Eldik,  1987).  Similarly, the calmodulin 
antisera exhibited no reactivity with purified S100~ or SI00/~ 
(Van Eldik et al.,  1983). The competition curves obtained 
for the various C6 fractions were parallel to those obtained 
with the purified S100 or calmodulin standards. In addition, 
the fractionation properties of S100  and  calmodulin  were 
identical in differentiated and undifferentiated cells. 
As shown in Fig. 4, differentiated C6 cells contained four- 
fold more S100/~ than undifferentiated C6 cells (75.6  ±  8 
fg/cell vs.  12.9  ±  2.5 fg/cell). Differentiated and undiffer- 
entiated C6 cells contained predominantly the $100/~ poly- 
peptide. In fact the S100o~ levels were so low that it was not 
possible  to determine if the  S100t~ immunoreactivity de- 
tected was due to cross-reactivity of the S100/3 antibody or 
a very small amount of S100c~ present in the cells. The cal- 
modulin levels were approximately threefold higher in differ- 
entiated (223.6  ±  10.9  fg/cell) compared with undifferen- 
tiated C6 cells (72.5 ±  5.5 fg/cell). In partially differentiated 
C6 cells-i.e., cells grown in serum-containing media sup- 
plemented  with  dcAMP  or  in  serum-free  media-Sl00/~ 
(28.8  ±  4.7  fg/cell) and calmodulin (145.8  ±  10.5)  levels 
were approximately half the levels seen in fully differentiated 
cells. When cells were treated with sodium butyrate, instead 
of dcAMP, the Sl00/~ and calmodulin levels in C6 cells did 
not change (data not shown),  in agreement with previous 
studies (Hirschfeld and Bressler, 1987). Thus, the levels of 
both S100/3 and calmodulin increase during morphological 
differentiation of C6 cells and appear to correlate with the 
degree of morphological differentiation. 
Figure 4. Immunoreactive levels of intraceUular S100o~, Sl00fl, and 
calmodulin in rat C6 cells grown under various culture conditions. 
The levels of SI00c~ (solid bars),  SI00/~ (striped bars),  and cal- 
modulin (stippled  bars) were determined by radioimmunoassay. 
The mean fg of Sl00ct, SI00/~, and calmodulin per cell + the SEM 
was then calculated. The total number of  determinations using three 
different preparations for each condition was 3. 
The Journal of Cell Biology,  Volume 108, 1989  146 Figure  5.  Subcellular distribution of S100B, TRITC-WGA, and calmodulin in rat C6 cells grown under various conditions. Fluorescent 
micrographs  of C6 cells grown in serum-containing  media (a, e, and i), serum-containing  media supplemented  with 1 mM dcAMP (b, 
f, and j), serum-free  media (c, g, and k), and serum-free  media supplemented  with  1 mM dcAMP (d, h, and l) are shown. Cells were 
permeabilized with coM acetone and incubated in an antiS100B IgG fraction (a-d) or an amicalmodulin IgG fraction (i-l) followed by 
an FITC-conjugated  goat anti-rabbit secondary amibody and TRITC-conjugated WGA. Cells in a-d and i-l were viewed with optics selec- 
tive for fluorescein to visualize the distribution  of S100/3 (a-d) or calmodulin  (i-l). The same fields shown in a-d were viewed with optics 
selective for rhodamine to visualize the distribution of WGA binding sites (e-h).  Bar,  1 /zm. SubceUular Distribution of  SlOOf3 and Calmodulin in 
Differentiated C6 Cells 
To determine whether the  increased levels  of S100~  and 
calmodulin in differentiated C6 cells resulted in a redistribu- 
tion of these proteins in the cytoplasm, the subcellular distri- 
butions  of  S100~  and  calmodulin  in  differentiated  and 
undifferentiated C6 cells were compared using indirect im- 
munofluorescence microscopy.  In differentiated C6  cells, 
S100B staining throughout the cytoplasm was observed (Fig. 
5 d) and the staining in the perinuclear cytoplasm appeared 
more intense than the staining in the nonperinuclear cyto- 
plasm. This staining pattern was significantly different from 
the staining pattern seen in undifferentiated cells; i.e.,  in- 
tense staining in a small region of the perinuclear cytoplasm 
(Fig. 5 a). These data suggest that during C6 cell differentia- 
tion, S100~  redistributes from a  small region of the peri- 
nuclear cytoplasm into the entire cytoplasm with somewhat 
higher concentrations being found throughout the perinucle- 
ar cytoplasm. In contrast, the calmodulin staining pattern did 
not change during differentiation of C6 cells.  In differen- 
tiated (Fig. 5 l), partially differentiated (Fig. 5, j and k), and 
undifferentiated  (Fig. 5 i) cells, calmodulin exhibited a punc- 
tate staining throughout the cytoplasm. 
While  populations  of  partially  differentiated  C6  cells 
(those grown in serum-containing media supplemented with 
dcAMP or in serum-free media) had indistinguishable mor- 
phologies, these two populations of cells could be distin- 
guished on the basis of S100~ subcellular distribution. In C6 
cells grown in serum-containing media supplemented with 
dcAMP (Fig. 5 b), the S100/~ staining pattern was similar to 
that seen in undifferentiated  C6 cells; i.e., staining in a small 
region of the perinuclear cytoplasm. In contrast; cells grown 
in serum-free media (Fig. 5 c) exhibited an S100/3 staining 
pattern that was similar to that seen in differentiated cells; 
i.e.,  a  diffuse staining pattern throughout the perinuclear 
cytoplasm and a less intense diffuse staining throughout the 
nonperinuclear cytoplasm. The redistribution of S100/3 dur- 
ing differentiation is accompanied by changes in the subcel- 
lular distribution of the Golgi apparatus as determined by 
TRITC-WGA staining. In differentiated C6 cells (Fig. 5 h) 
TRITC-WGA  labeling  is  located  in  a  vesicular  pattern 
throughout the perinuclear cytoplasm rather than the small 
region of the perinuclear cytoplasm seen in undifferentiated 
cells (Fig. 5 e).  The two populations of partially differen- 
tiated  cells  could  also  be  distinguished  on  the  basis  of 
TRITC-WGA  staining patterns.  C6 cells grown in serum- 
containing media supplemented with dcAMP (Fig. 5 f) ex- 
hibited  a  TRITC-WGA  staining  pattern,  which  was  very 
similar to that seen in undifferentiated  cells (Fig. 5 e), while 
those grown in serum-free media (Fig. 5 g) had a TRITC- 
WGA staining pattern, which was identical to that seen in 
differentiated cells (Fig. 5 h). Thus, changes in the subcellu- 
lar distribution of  the Golgi membranes occur during in vitro 
differentiation of C6 cells but do not correlate with the de- 
gree of morphological differentiation. 
SIO0 and Calmodulin Target Proteins in C6 Cells 
Calcium-modulated proteins such as calmodulin and SIO0 
can interact with and modulate the activity of other proteins. 
Thus,  calcium-dependent cellular processes may be regu- 
lated by changes in these target proteins instead of or in addi- 
Figure 6. SI00- and calmodulin-binding  proteins in C6 cells grown 
under various culture conditions. The supernatant fractions of C6 
cells grown in serum-containing  media (lane 1), serum-containing 
media supplemented  with 1  mM dcAMP (lane 2), serum-free  media 
(lane 3), or serum-free media supplemented with 1 mM dcAMP 
(lane  4)  were subjected to  electrophoresis in  12.5% (wt/vol) 
acrylamide-SDS gels, and 125I-S100/3- and 12SI-calmodulin-binding 
proteins were detected by using the gel overlay technique. (A) 
Coomassie Blue-stained  gel  profile. Corresponding autoradio- 
grams of gels incubated in (B) t25I-S100/~, or (C)125I-calmodulin  in 
the presence of 0.1 mM calcium. Molecular weight standards are 
shown (X10  -3) on the left. 
tion to changes in the levels and/or subcellular distribution 
of the calcium-modulated proteins. Therefore, a gel overlay 
procedure  was  used  to  examine S100/3- and  calmodulin- 
binding proteins  in differentiated and undifferentiated C6 
cells (Fig. 6).  This is a qualitative procedure that has been 
used in previous studies of S100- and calmodulin-binding 
proteins (Burgess et al., 1984; Zimmer and Van Eldik, 1987) 
and allows rapid screening and detection of binding proteins 
in crude extracts. 
Comparison  of  the  S100~-binding  protein  profile  of 
undifferentiated (Fig. 6 B, lane/) and differentiated C6 cells 
(Fig. 6 B, lane 4) demonstrated a reduction in the intensity 
of binding proteins in the 20,000-43,000  mol wt range and 
an  increase  in  the  intensity  of  binding  proteins  in  the 
14,000-20,000  mol  wt  range  in  differentiated cells.  The 
calmodulin-binding proteins in the 43,000-150,000  mol wt 
range did not appear to change in intensity during differentia- 
tion (compare Fig. 6 C, lanes 1 and 4). However, calmodu- 
lin-binding proteins in the 25,000-40,000  mol wt range de- 
creased in intensity while those in the 14,000-17,000 mol wt 
range increased in intensity in differentiated cells. Overall, 
the S100/~- and calmodulin-binding  protein profiles were dis- 
tinct, suggesting that S100~ and calmodulin have different in- 
tracellular targets in C6 cells. However, in both differentiated 
and  undifferentiated  cells  some  S100-  and  calmodulin- 
binding proteins have similar apparent molecular weights, 
suggesting that S100/3 and calmodulin may have some com- 
mon target proteins in C6 ceils. Partially differentiated C6 
cells (those grown in serum-containing media supplemented 
with dcAMP [Fig. 6, lanes 2] or in serum-free media [Fig. 
6, lanes 3]) had different S100/3- (Fig. 6 B, lanes 2 and 3) and 
calmodulin-binding protein profiles (Fig. 6 C, lanes 2 and 3) 
even though these cells have similar morphologies. Thus, 
major changes  in  S100~-  and calmodulin-binding protein 
profiles occur during differentiation of C6 cells but do not 
correlate with the degree of morphological differentiation. 
The Journal  of Cell Biology,  Volume 108, 1989  148 Aldolase Hybrids in C6 Cells 
While the gel overlay technique is useful for screening heter- 
ogeneous protein fractions for S100-binding activity, it does 
not allow one to detect changes in the isozymic composition 
of a binding protein. The effect of S100 on one S100-binding 
protein, fructose-l,6-bisphosphate aldolase, varies with each 
isozyme: the C, or brain-specific, isozyme shows calcium- 
dependent stimulation by S100 while the A isozyme shows 
calcium-independent stimulation by SI00 (Zimmer and Van 
Eldik,  1986).  In addition, previous studies have suggested 
that the isozymic composition of aldolase in glial cells may 
be developmentally regulated (Sato et al.,  1972; Kumanishi 
et al.,  1985). To determine whether the aldolase isozymes 
changed  during  C6  cell  differentiation,  we  used  a  non- 
denaturing gel system to examine the aldolase isozyme com- 
position of C6 cells at various stages  of differentiation. Na- 
tive aldolase is a tetramer, and in ceils and tissues such as 
muscle, which contain only the A isozyme, a single aldolase 
hybrid (A4) is seen on nondenaturing gels (Fig. 7, lane/). 
In contrast, in tissues such as brain, which contain both the 
A and C aldolase isozymes, five aldolase hybrids (A4, A3CI, 
A2C2, AIC3, and C4) are visible on nondenaturing gels (Fig. 
7, lane 2). Undifferentiated C6 cells contain only the A iso- 
zyme as evidenced by the presence of only the A4 aldolase 
hybrid (Fig. 7, lane 3). However, differentiated C6 cells con- 
tain both the A and C isozymes as evidenced by the presence 
ofaldolase hybrids which contain C subunits (predominantly 
the A2C2, AIC3, and C4 hybrids) (Fig. 7, lane 6). Examina- 
tion  of  the  aldolase  isozyme  composition  in  partially 
differentiated cells revealed that, while these cells had indis- 
tinguishable morphologies (cells grown in serum-containing 
media  supplemented  with  dcAMP  (Fig,  7,  lane  4)  or  in 
serum-free media (Fig. 7, lane 5), they had distinct aldolase 
isozyme patterns.  Cells grown in serum-containing media 
containing dcAMP contained only the A aldolase isozyme as 
evidenced by the presence of only the A4 aldolase hybrid on 
Figure Z AMolase hybrids in C6 cells grown under various culture 
conditions.  An  aldolase-enriched  fraction  (45-60%  ammonium 
sulfate fraction) from C6 cells grown in serum-containing media 
(lane  3),  serum-containing  media  supplemented  with  1  mM 
dcAMP (lane 4), serum-free media (lane 5), and serum-free media 
supplemented with 1 mM dcAMP (lane 6) were subjected to elec- 
trophoresis on 5 % nondenaturing polyacrylamide gels. Commer- 
cially prepared muscle aldolase and purified rat brain aldolase are 
shown in lanes 1 and 2, respectively. Aldolase hybrids were visual- 
ized by using an activity stain. 
nondenaturing gels. In contrast, cells grown in serum-free 
media contained both the A and C aldolase isozymes as evi- 
denced by the presence of  aldolase hybrids on nondenaturing 
gels that contain the C  isozyme (predominantly the A3C~, 
A2C2, and A~,C3 hybrids). Thus, our data suggest that there 
is  an  increase  in  the  level  of the  C  aldolase  isozyme in 
differentiated C6 cells, and this increase does not correlate 
with the degree of morphological differentiation. 
Discussion 
We have examined the level,  subcellular distribution,  and 
target proteins of the calcium-modulated proteins S10013  and 
calmodulin in undifferentiated, partially differentiated, and 
differentiated glial cells, and these results are summarized in 
Table I.  The levels,  subcellular distribution,  and binding- 
protein profiles for S100/3 were distinct in differentiated and 
undifferentiated cells,  suggesting that S100/3 mediates new 
cellular processes in differentiated cells. While the levels and 
binding protein profiles for calmodulin were also distinct in 
differentiated and undifferentiated cells, the subcellular dis- 
tribution  of calmodulin  was  not  altered.  When  partially 
differentiated populations of C6  cells were examined,  we 
found that some of these parameters correlated with the de- 
gree of morphological differentiation while others did not 
(see Table I). Thus, the in vitro differentiation of rat glioma 
cells is a complex event in which multiple mechanisms ap- 
pear to regulate the function of calmodulin and S100B. 
Our results regarding S100  levels in C6 cells at various 
stages of differentiation agree with previous studies using in 
vitro and in vivo systems to analyze glial cell function. Other 
investigators have observed a  2-2.5-fold increase in  S100 
levels in  C6  cells grown in  serum-containing media  sup- 
plemented with  dcAMP  (Labourdette and  Mandel,  1980; 
Higashida et al.,  1985). Increases in S100 levels in C6 cells 
grown in serum-free media have also been reported. How- 
ever, we observed a 200% increase compared with the 50% 
increase seen by others (Fan and Uzman, 1977). This differ- 
ence may reflect different compositions of the  serum-free 
media. There are no previous reports regarding S100 levels 
in C6 cells grown in serum-free media supplemented with 
dcAMP.  While  these  previous  studies  did  not  determine 
which SI00 polypeptide(s) was responsible for the increased 
S100 levels, our study demonstrates that increased levels of 
S100 of rat glioma cells are due to increased levels of the 
S100t3 polypeptide. This is in agreement with in vivo studies 
that have shown that only the S10013 polypeptide is expressed 
in rat brain (Baudier et al., 1985; Kuwano et al., 1986). Our 
results are also consistent with developmental studies of rat 
that have demonstrated increased S100 levels in brain during 
development that correlate with differentiation of glial cells 
(Cicero et al.,  1972; Ghandour et al.,  1981; Kuwano et al., 
1987). 
The different binding protein profiles and subcellular dis- 
tributions of S100/3 and calmodulin suggest that these pro- 
teins modulate the activity of different intracellular proteins 
and thus have distinct functions in glial ceils. However, there 
are some areas of the cell cytoplasm that contain both S100/3 
and  calmodulin  immunoreactivity  and  some  S100/~- and 
calmodulin-binding  proteins  that  have  similar  molecular 
weights on SDS gels suggesting that S100 and calmodulin 
may share certain intracellular targets. An apparent increase 
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Protein levels* 
Culture  Calmod- 
conditions  Morphology  SI00B  ulin  S100/3 
Distribution  Target  proteins 
Calmodulin  S 100B*  Calmodulin*  Aldolase 




Serum  +  Larger,  2  1.5  Intense staining 
dcAMP  elongated  small region 
perinuclear 
cytoplasm 
Serum free  Larger,  2  1.5  Diffuse staining 
elongated  throughout 
cytoplasm 
Serum free  Astrocyte-  4  3  Diffuse staining 
+  dcAMP  like  throughout 
cytoplasm 
Punctate staining  20,000-43,000  43,000-150,000  A 
throughout  14,000-20,000  25,000-40,000 
cytoplasm  14,000-17,000 
Punctate staining  20,000-43,000  43,000-150,000  A 
throughout  14,000-20,000  25,000-40,000 
cytoplasm  14,000-17,000 
Punctate staining  20,000-43,0004  43,000-150,000  A  and C 
throughout  14,000-20,0001'  25,000-40,000~ 
cytoplasm  14,000-17,000f 
Punctate staining  20,000-43,000~  43,000-150,000  A  and C 
throughout  14,000-20,000't'  25,000-40,000~ 
cytoplasm  14,000-17,000¢ 
* Normalized  to values seen with serum. 
* Increases  in intensity are indicated by t  and decreases  by J,. 
in the C isozymic form of aldolase, an S100-binding protein, 
occurs during glial cell differentiation. These results are con- 
sistent with in vivo studies which have demonstrated that al- 
dolase C  is found in glial cells in vivo (Thompson et al., 
1982) and with in vitro studies which suggest that the level 
of aldolase  C  correlates  with  the  degree  of glioma  cell 
differentiation (Kumanshi et al.,  1975). 
Our study also provides new information regarding the as- 
sociation  of S100/3 with  specific  intracellular  structures. 
Using double fluorescent labeling techniques, we have been 
able to demonstrate that S100B immunoreactivity colocalizes 
with the Golgi apparatus and MTOC in undifferentiated C6 
cells and  that  this  localization  is  dependent on  an  intact 
microtubule complex. Selective permeabilization techniques 
suggest that significant levels of S100/3 are present on the cy- 
toplasmic surface and not on the inside of the Golgi appara- 
tus. Altogether these data suggest that S100B is closely as- 
sociated with the MTOC in undifferentiated C6 cells. The 
significant change in the subcellular distribution of S100/3 in 
differentiated cells to include the entire cytoplasm suggests 
that S100~ mediates different processes in differentiated glial 
cells. 
The association of S100~ with the MTOC suggests that 
one function of S100 in glial cells may be the regulation of 
cell architecture and/or motility via interaction of S100 with 
microtubules or microtubule-associated proteins.  Previous 
immunolocalization studies onmitotic C6 cells have demon- 
strated that S100/~ colocalizes with the mitotic spindle (Zim- 
mer and Van Eldik, 1988), suggesting that S100 may have a 
similar function in mitotic ceils. Studies from other laborato- 
ries (Donato, 1986,  1988) have demonstrated that S100 can 
affect microtubule assembly in vitro supporting the hypothe- 
sis that S100 may regulate cell shape and/or motility. The 
molecular mechanisms of S100 regulation of microtubule as- 
sembly in vivo are unknown. However, studies by Baudier 
et al. (1987,  1988) have demonstrated that S100 interacts in 
vitro, in a calcium-dependent manner, with r proteins. These 
previous studies suggest that S100 may act via a Ca+2-S100  - 
z complex, analogous to that proposed for calmodulin (Lee 
and Wolff, 1984). More information regarding the exact na- 
ture of the association of S100 with the MTOC and spindle 
apparatus,  and  S100  target  proteins  associated  with  the 
MTOC and spindle will be necessary before the role of S100 
in  regulating cell architecture and  motility can be ascer- 
tained. 
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